Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Continuing Medical Education: November 2012

American Journal of Gastroenterology: November 2012 - Volume 107 - Issue 11 - p 1713
doi: 10.1038/ajg.2012.357
ORIGINAL CONTRIBUTIONS: FUNCTIONAL GI DISORDERS
Buy

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation

The American College of Gastroenterology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American College of Gastroenterology designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Creditâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

© The American College of Gastroenterology 2012. All Rights Reserved.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website